Canadian breast cancer guidelines: Have they made a difference?

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 6, 2007, Pages 771-776

  Latosinsky, Steven ^a,b,c   Fradette, Katherine ^a   Lix, Lisa ^b   Hildebrand, Karen ^a   Turner, Donna ^a,b  

^a CANCERCARE MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY ARTERY; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT CARE; SURGICAL TECHNIQUE;

EID: 33947411418     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060854     Document Type: Article

References (18)

1. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer. CMAJ 1998;158(3 Suppl).1-83.
2. Health Canada. Progress report on cancer control in Canada. Ottawa: Health Canada; 2004. Cat no H39-4/50-2004E. Available: www.phac-aspc.gc.ca/ publicat/prccc-relccc/pdf/F244_HC_Cancer_Rpt_English.pdf (accessed 2007 Jan 24).
3. Breast. In: Fleming ID, Cooper JS, Henson D, editors. American Joint Committee on Cancer cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997.
4. McCulloch CE, Searle SR. Generalized, linear, and mixed models. New York: John Wiley and Sons; 2001.
5. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. New York: John Wiley and Sons; 2004.
6. Iscoe NA, Goel V, Wu K, et al. Variation in breast cancer surgery in Ontario. CMAJ 1994;150:345-52.
7. Guadagnoli E, Weeks JC, Shapiro CL, et al. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 1998;16:101-6.
8. Gaudette LA, Gao RN, Spence A, et al. Declining use of mastectomy for invasive breast cancer in Canada, 1981-2000. Can J Public Health 2004;95:336-40.
9. Bland KI, Scott-Conner CE, Menck H, et al. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 1999;188: 586-95.
10. Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-8.
11. Schaapveld M, Otter R, de Vries EG, et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol 2004;87:4-12.
12. White V, Pruden M, Giles G, et al. The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 2004;101: 476-85.
13. McEvoy SP, Ingram DM, Byrne MJ, et al. Breast cancer in Western Australia: clinical practice and clinical guidelines. Med J Aust 2004;181(6):305-9.
14. Sawka C, Olivotto I, Coldman A, et al. The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. British Columbia/Ontario Working Group. Br J Cancer 1997;75:1534-42.
15. Iscoe NA. We may get this horse to water, but will it drink? CMAJ 1998;158:345-6.
16. Bahtsevani C, Uden G, Willman A. Outcomes of evidence-based clinical practice guidelines: a systematic review. Int J Technol Assess Health Care 2004;20:427-33.
17. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:iii-iv, 1-72.
18. Browman G. National guideline workshop backgrounder. The clinical practice guideline 'life cycle'. 2002 July 12. Available: http://209.217.127.72/ cscc/pdf/priorities_pdf/CPG_LifeCycle.PDF (accessed 2007 Jan 30).